Target intelligence / Profile preview

RNA, U6 small nuclear 952, pseudogene (RNU6-952P)

Target: RNU6-952P
Molecular classification: Pseudogene, Noncoding RNA (derived from snRNA), Small nuclear RNA (snRNA), processed pseudogene

Overview

RNA, U6 small nuclear 952, pseudogene (RNU6-952P) is a processed pseudogene in the human genome that shares sequence similarity with U6 small nuclear RNA, a core component of the spliceosome involved in pre-mRNA splicing[1][4][6]. Unlike the functional U6 snRNA gene, RNU6-952P does not encode an active RNA or protein and is generally considered nonfunctional. Its biological role, if any, remains uncertain, and it is not implicated in disease, drug interaction, or therapeutic targeting[1][4][2]. RNU6-952P is a pseudogene, not a true molecular target. It should not be chosen as a therapeutic target, biomarker, or druggable entity. Its annotation is correct as a noncoding RNA pseudogene; no function or disease association is known[1][4][2].

Other names: RNU6-952PRNA, U6 small nuclear 952, pseudogene

Mechanism of action

None known; no drugs target RNU6-952P.

Biological functions

Most pseudogenes do not encode functional proteins. Some may have regulatory RNA roles (e.g., acting as competing endogenous RNAs or miRNA sponges), but this is not established for RNU6-952P specifically.In general, U6 snRNA is involved in pre-mRNA splicing, but pseudogenes like RNU6-952P are not functional in this process.

Disease associations

None known directly for RNU6-952P. Other pseudogenes may be involved in diseases (e.g., cancer) through regulatory mechanisms, but no evidence for RNU6-952P.

Safety considerations

None known; does not represent a safety or therapeutic challenge.

Interacting drugs

None known.

Biomarkers

None known; not used as a biomarker.

Beyond the preview

Go deeper on RNA, U6 small nuclear 952, pseudogene (RNU6-952P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 952, pseudogene (RNU6-952P).

Explore the full profile